Hermay Labs Corp.
Alberta, Canada
As a participant of the upcoming symposium “2nd GCCIR Matchmaking Symposium” organized by Innoget and GCCIR next November 25th, 2019 in Barcelona (Spain), the company Hermay Labs Corp. is seeking European partners to meet at the Barcelona event to develop a joint collaboration project.
Hermay Labs Corp. is specifically interested in European partners with expertise in biology, drug discovery and cosmetics. Further details are described below.
In case you are interested in meeting Hermay Labs Corp. in Barcelona to discuss a potential collaboration, please register for free to the symposium clicking the “Register to the symposium” button above.
Hermay Labs Corp. is a high-tech research organization dedicated to conducting high quality research and development. The company has developed a range of tyrosinase-targeted agents that offer potential cosmetic modulation of skin depigmentation and chemotherapy of advanced melanoma. Skin pigmentation control and melanoma chemotherapy are serious goals for people in all walks of life.
Cosmetically affected individuals suffering from exposure to occupational or recreational exposure sunlight including sun tanning; or experiencing drug-induced hyperpigmentation, look to the cosmetic industry for help. Similarly, the lack and ineffectiveness of melanoma-targeted drugs leave chemotherapy as a last attempt for advanced-stage melanoma treatment.
Therefore, Hermay Labs Corp. has developed a series of compounds that represent a new opportunity to interrupt skin hyperpigmentation and modulate melanoma growth at a major biomolecular level.
The objective of this matchmaking trip is to find partners that will help the company with its Melanoma project. Hermay Labs Corp. has developed a group of lead compounds and is looking for partners who can help test the in vitro activities of these compounds and then conduct further optimization.
The following are the important aspects Hermay Labs Corp. is looking for in a European partner:
Category of the call
Partners for consortium
Funding available
€ 500,000
Entity offering the program
GCCIR/ACCIO
Deadline
24-11-2019